Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
14
14 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- PovetaciceptALPN-303Phase 37 trials
Vertex Pharmaceuticals · Immunoglobulin A Nephropathy, Myasthenia Gravis, Generalized, Primary Membranous Nephropathy
- VX-121D-IVA, CTP-656Phase 33 trials
Vertex Pharmaceuticals · Cystic Fibrosis
- matched to PregabalinPhase 32 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain
- matched to SUZPhase 32 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain
- VX-147Inaxaplin, IXPPhase 32 trials
Vertex Pharmaceuticals · Proteinuric Kidney Disease
- ZimislecelFormerly known as STx-02, VX-880Phase 32 trials
Vertex Pharmaceuticals · Type 1 Diabetes, Kidney Transplant, Diabetes Mellitus, Type 1
- Exa-celPhase 31 trial
Vertex Pharmaceuticals · Sickle Cell Disease, Hematological Diseases, Hemoglobinopathies
- matched to PovetaciceptPhase 31 trial
Alpine Immune Sciences Inc, A Subsidiary of Vertex · Immunoglobulin A Nephropathy
- VX-017Phase 31 trial
Vertex Pharmaceuticals · Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia
- matched to VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- VX-670Phase 22 trials
Vertex Pharmaceuticals · Myotonic Dystrophy Type 1 (DM1)
- VX-993Phase 22 trials
Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain
- VX-264Phase 21 trial
Vertex Pharmaceuticals · Type 1 Diabetes
- VX-407Phase 21 trial
Vertex Pharmaceuticals · Autosomal Dominant Polycystic Kidney Disease (ADPKD)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.